Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in exhaled nitric oxide levels with immunotherapy.

Chitra Dinakar1, Thomas J Van Osdol, Charles S Barnes

  • 1Section of Allergy/Asthma/Immunology, Children's Mercy Hospital, Kansas City, Missouri 64108, USA. cdinakar@cmh.edu

Allergy and Asthma Proceedings
|May 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease.

The journal of allergy and clinical immunology. In practice·2025
Same author

Specific IgE point-of-care testing is evolving.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Myriad of Mucocutaneous Manifestations in Multisystem Inflammatory Syndrome Associated with COVID-19.

Indian journal of pediatrics·2023
Same author

Severity and mortality associated with COVID-19 among children hospitalised in tertiary care centres in India: a cohort study.

The Lancet regional health. Southeast Asia·2023
Same author

Why allergists should care about optimizing fungal allergen culture.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023
Same author

Congenital syphilis: a rare presentation of a forgotten infection.

Journal of infection in developing countries·2023

Rush immunotherapy (IT) in children with allergic airway disorders causes a rapid rise in exhaled nitric oxide (eNO) levels, a marker of inflammation. These levels then decrease, indicating immunomodulatory changes during treatment.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Biomarkers

Background:

  • Immunotherapy (IT) modulates allergic airway responses, but mechanisms remain unclear.
  • Exhaled nitric oxide (eNO) is a sensitive marker for airway inflammation in allergic respiratory disorders.

Purpose of the Study:

  • To characterize eNO patterns in children receiving traditional IT (TradIT) versus rush IT (RushIT).
  • To investigate eNO as a potential barometer of immunomodulatory changes during IT.

Main Methods:

  • Off-line eNO measurements were taken in children undergoing TradIT or RushIT.
  • eNO levels were recorded before IT initiation and at 2, 4, 6, 8, and 12 weeks post-initiation.
  • Nine children received TradIT, and 10 received RushIT.

Related Experiment Videos

Main Results:

  • RushIT group showed an initial rise in eNO (12.6 to 17.7 ppb by week 2), peaking by week 8, then dropping below baseline by week 12 (p=0.038).
  • TradIT group did not exhibit similar eNO changes.
  • The difference in eNO levels between groups was significant at 4 weeks (p=0.014).

Conclusions:

  • Initiation of IT induces significant immunomodulatory changes, reflected by alterations in eNO levels.
  • These immunomodulatory changes appear accelerated with RushIT compared to TradIT.
  • eNO levels return to baseline as maintenance IT levels are achieved.